WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Julie RubinsteinPresident and COO2026-04-2719,037$14.23
$270.90kSell
Julie RubinsteinPresident and COO2026-04-2714,707$8.46
$124.42kBuy
Julie RubinsteinPresident and COO2026-04-2414,722$8.46
$124.55kBuy
Julie RubinsteinPresident and COO2026-04-2419,060$14.02
$267.22kSell
Julie RubinsteinPresident and COO2026-04-2314,722$8.46
$124.55kBuy
Julie RubinsteinPresident and COO2026-04-2319,060$13.74
$261.88kSell
Julie RubinsteinPresident and COO2026-04-2219,060$14.13
$269.32kSell
Julie RubinsteinPresident and COO2026-04-2214,722$8.46
$124.55kBuy
Julie RubinsteinPresident and COO2026-04-2130,941$14.66
$453.60kSell
Julie RubinsteinPresident and COO2026-04-2111,881$12.14
$144.24kBuy

1 of 18

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC20.13%30,993,708$449.41MInsider
Viking Global Investors LP19.48%29,993,708$434.91MInsider
Viking Global Investors LP19.48%29,993,708$434.91MInstitution
Blackrock Inc8.66%13,333,559$193.34MInstitution
David E. Goel7.99%12,310,594$178.50MInsider
Vanguard Group Inc7.33%11,282,152$163.59MInstitution
Chad M. Robins3.65%5,618,018$81.46MInsider
Price T Rowe Associates Inc2.85%4,387,361$63.62MInstitution
Westfield Capital Management Co LP2.64%4,060,481$58.88MInstitution
Andris A. Zoltners2.35%3,621,016$52.50MInsider

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT63.04%36.96%Net SellingNet Selling
OCUL83.71%16.29%Net SellingNet Selling
AUPH54.35%13.23%Net BuyingNet Buying
TRVI43.05%56.95%Net Buying
AAPG0.01%22.93%
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 97.65% institutional shareholders, 57.24% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 20.13% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $427.09M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.